iRhythm Technologies Inc (IRTC)
73.99
+0.09
(+0.12%)
USD |
NASDAQ |
Nov 22, 16:00
73.88
-0.10
(-0.14%)
After-Hours: 20:00
iRhythm Technologies Debt to Equity Ratio: 8.999 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
September 30, 2024 | 8.999 |
June 30, 2024 | 6.502 |
March 31, 2024 | 7.133 |
December 31, 2023 | 0.1664 |
September 30, 2023 | 0.159 |
June 30, 2023 | 0.1561 |
March 31, 2023 | 0.1575 |
December 31, 2022 | 0.1457 |
September 30, 2022 | 0.146 |
June 30, 2022 | 0.1428 |
March 31, 2022 | 0.1426 |
December 31, 2021 | 0.0764 |
September 30, 2021 | 0.082 |
June 30, 2021 | 0.0887 |
March 31, 2021 | 0.0972 |
December 31, 2020 | 0.0966 |
September 30, 2020 | 0.1045 |
June 30, 2020 | 0.2963 |
Date | Value |
---|---|
March 31, 2020 | 0.2795 |
December 31, 2019 | 0.258 |
September 30, 2019 | 0.245 |
June 30, 2019 | 0.7185 |
March 31, 2019 | 0.7023 |
December 31, 2018 | 0.6694 |
September 30, 2018 | 0.509 |
June 30, 2018 | 0.4758 |
March 31, 2018 | 0.4686 |
December 31, 2017 | 0.4271 |
September 30, 2017 | 0.3927 |
June 30, 2017 | 0.3784 |
March 31, 2017 | 0.3656 |
December 31, 2016 | 0.3482 |
September 30, 2016 | -0.2767 |
June 30, 2016 | -0.282 |
March 31, 2016 | |
December 31, 2015 | -0.3006 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.0764
Minimum
Dec 2021
8.999
Maximum
Sep 2024
1.262
Average
0.151
Median
Debt to Equity Ratio Benchmarks
Abbott Laboratories | 0.3764 |
Boston Scientific Corp | 0.5254 |
Perspective Therapeutics Inc | -- |
Xtant Medical Holdings Inc | 0.7605 |
Catheter Precision Inc | 0.1364 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 909.69M |
Total Liabilities (Quarterly) | 837.92M |
Shareholders Equity (Quarterly) | 71.77M |
Current Ratio | 6.273 |
Net Debt Paydown Yield | -5.26% |